By G HossainPosted on November 10, 2025Posted in Pharmaceutical & Bio Science, UncategorizedTagged bio science career, blogs, business career news, career tips, job blog, job news, RJF Pharmaceutical Jobs MeiraGTx Holdings is licensing a genetic eye disease medicine to Eli Lilly in a deal worth up to $475 million. Lilly Doubles Down on Eye Diseases, Adding to BD Spree Post navigation Lilly Makes $1.2B RNAi Pact With SangeneBio, Targets Metabolic DiseasesDespite Obesity Drug Pricing Deal, GLP-1 Compounders Continue To Operate in the Shadows